| Trial ID: | L0388 |
| Source ID: | ChiCTR2100044996
|
| Associated Drug: |
Losartan
|
| Title: |
A randomized controlled clinical trial of polyethylene glycol losartan in the treatment of nonalcoholic steatohepatitis (NASH)
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease
|
| Interventions: |
control group:Glutathione;experimental group:Glutathione+polyethylene glycol losartan;
|
| Outcome Measures: |
Blood fat;Fasting blood glucose;HbA1c;Serum insulin;HOMA-IR;Cytokeratin CK-18 (M30 and M65);Transabdominal ultrasound;Fat content determination;Liver elasticity value;Weight;Waistline;BMI;Heart function;Liver function;Kidney function;Routine blood test;
|
| Sponsor/Collaborators: |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
|
| Gender: |
All
|
| Age: |
18nan
|
| Phases: |
Not applicable
|
| Enrollment: |
control group:100;experimental group:100;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Parallel
|
| Start Date: |
03/04/2021
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 November 2021
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=124434
|
